Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer

Go back to Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer
(NASDAQ: TERN) Delayed: 52.95 --0 (-0%)
Previous Close $52.95    52 Week High
Open $52.95    52 Week Low
Day High $52.95    P/E N/A 
Day Low $52.95    EPS
Volume 17,467